CALM Technologies has been selected as the implementation partner for the NIH/NIAMS BioMED-ISS grant, awarded to Dr. Paola Divieti, M.D., PhD of Massachussets General Hospital/Harvard Medical School.  The NIH grant will allow research on Osteocytes to be performed on the International Space Station, through the use of CALM Technologies' eOSTEO bone cell research facility.   With the hardware being made available by the Canadian Space Agency for retrofit to the International Space Station, the eOSTEO system will continue the legacy of the OSTEO payload, which flew on two shuttle missions, STS-95 and STS-107.  The eOSTEO payload flew Canadian and European research aboard a Russian Soyuz rocket, and orbited for two weeks on the Foton-M3 capsule in September 2007. 

The NIH Press release can be viewed by following this link: http://www.nih.gov/news/health/sep2010/niams-01.htm

CALM technologies has announced the launch of its first commercial product line, the SEAM electrode testing family of products.  The SEAM ECG Electrode testing system is designed to allow manufacturing tests of disposable electrodes to the AAMI/ANSI EC12:2000 standard. 

The Canadian Space Agency has extended CALM Technologies' contract for the Cell Culture and Analysis Payload (CCAP) to include additional testing, based on the success of the technology demonstrations to date.  The CCAP payload has been identified as the next generation platform for performing tissue and cell culture experiments on-orbit, and will help maintain Canada's role as a major player in the life sciences branch of microgravity research.